Le Lézard
Classified in: Health
Subjects: PER, SCZ

Remedi SeniorCare Hires Michael Hovis, PharmD, as General Manager of Huntsville Pharmacy


BALTIMORE, Dec. 17, 2019 /PRNewswire/ -- Jeffrey M. Stamps, R.Ph., President and CEO of Baltimore-based Remedi SeniorCare, announces the hiring of the general manager for a new pharmacy in Huntsville, Alabama. Long-term care pharmacy executive, Michael Hovis, PharmD, has joined Remedi as development progresses on the company's thirteenth location. Slated to open in the first quarter of 2020, the 36,000 square foot pharmacy will dispense Remedi's proprietary dispensing system, PAXIT®, and will eventually employ more than 200 individuals.

Remedi SeniorCare Pharmacy. (PRNewsFoto/Remedi SeniorCare)

As a PharmD graduate from Purdue University licensed in multiples states, Michael brings over a decade of pharmacy experience to Remedi SeniorCare. His career has spanned retail, hospital, and, most recently, long-term care settings where he was responsible for over 24,000 beds. As general manager, Michael will oversee all pharmacy operations to ensure compliance with all aspects of medication administration preparation and delivery to Remedi's customers. Various departments include order entry, medical records, fulfillment operations, R.Phs, delivery, and customer service. Mark Schroder, R.Ph., Remedi's Chief Operating Officer, notes, "Michael's experience and passion make him an ideal leader for our new pharmacy in Huntsville. We look forward to our eventual opening and bringing PAXIT to more providers in the Southeastern United States."

A leading innovator in long-term care pharmacy, Remedi SeniorCare brings cutting-edge technology, which is transforming the long-term care service model. As the exclusive provider of the patented PAXIT medication administration system, Remedi SeniorCare has a long history of providing cost-effective and highly accurate pharmacy medication pass services to long-term care facilities, including skilled nursing facilities and assisted living communities. Remedi SeniorCare supports more than 80,000 residents across 32 states and the District of Columbia. Through its technology-enabled pharmacy services, Remedi SeniorCare allows its customers to achieve higher levels of accuracy and quality in medication delivery while reducing unnecessary waste and cost.

For more information, visit www.RemediRx.com.

SOURCE Remedi SeniorCare


These press releases may also interest you

at 06:00
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on April 25, 2024, the Compensation Committee of IDEAYA's Board of Directors granted...

at 06:00
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to...

at 06:00
Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first...

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 04:00
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...



News published on and distributed by: